뇌전증지속상태로 내원한 코로나-19 뇌염 환자에서 가역적 변화가 관찰된 세포독성부종
Reversible Cytotoxic Edema in Patients with COVID-19 Associated Encephalitis Presenting Status Epilepticus
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Coronavirus disease 2019 (COVID-19) is a serious infectious disease with multisystem alteration including neurological complications. COVID-19 associated encephalitis is a potentially fatal viral infection of the brain. Diffusion-weighted images (DWI) are a useful evaluation modality of cytotoxic edema in patients with encephalitis. We report on the reversible DWI change in a patient with COVID-19 associated encephalitis, who had diffused cytotoxic edema in the affected temporal lobe and accompanied status epilepticus. Sequential imaging showed that the cytotoxic edema in DWI confirmed recovery to normal after 12 days in the presence of cortical edema in fluid-attenuated inversion recovery image after aggressive neurocritical management. Thus, prompt, proper management is indispensable during the acute period and DWI may be a valuable tool for reflecting the clinical course of COVID-19 associated encephalitis.
Abstract
Coronavirus disease 2019 (COVID-19) is a serious infectious disease with multisystem alteration including neurological complications. COVID-19 associated encephalitis is a potentially fatal viral infection of the brain. Diffusion-weighted images (DWI) are a useful evaluation modality of cytotoxic edema in patients with encephalitis. We report on the reversible DWI change in a patient with COVID-19 associated encephalitis, who had diffused cytotoxic edema in the affected temporal lobe and accompanied status epilepticus. Sequential imaging showed that the cytotoxic edema in DWI confirmed recovery to normal after 12 days in the presence of cortical edema in fluid-attenuated inversion recovery image after aggressive neurocritical management. Thus, prompt, proper management is indispensable during the acute period and DWI may be a valuable tool for reflecting the clinical course of COVID-19 associated encephalitis.
참고문헌 (10)
- Ellul MA, "Neurological associations of COVID-19", Lancet Neurol, 19, pp.767~783 (2020)
- Islam MA, "Encephalitis in patients with COVID-19 : a systematic evidencebased analysis", Cells, 11, pp.2575~ (2022)
- Caroli A, "Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations", Neuroimage Clin, 37, pp.103338~ (2023)
- Liang D, "Cytotoxic edema : mechanisms of pathological cell swelling", Neurosurg Focus, 22, pp.E2~ (2007)
- Gaddamanugu S, "Clinical applications of diffusion-weighted sequence in brain imaging : beyond stroke", Neuroradiology, 64, pp.15~30 (2022)
- Gaur P, "COVID-19-associated cytotoxic lesions of the corpus callosum", AJNR Am J Neuroradiol, 41, pp.1905~1907 (2020)
- Sener RN, "Herpes simplex encephalitis : diffusion MR imaging findings", Comput Med Imaging Graph, 25, pp.391~397 (2001)
- Alam AM, "Increased volume of cerebral oedema is associated with risk of acute seizure activity and adverse neurological outcomes in encephalitis-regional and volumetric analysis in a multi-centre cohort", BMC Neurol, 22, pp.412~ (2022)
- Kiroğlu Y, "Diffusion-weighted MR imaging of viral encephalitis", Neuroradiology, 48, pp.875~880 (2006)
- Huang TH, "Brain imaging in epilepsyfocus on diffusion-weighted imaging", Diagnostics(Basel), 12, pp.2602~ (2022)